Replimune Group Inc

NASDAQ:REPL  
30.00
-0.63 (-2.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Replimune Group, Inc. Stock, NASDAQ:REPL

500 Unicorn Park, Woburn, Massachusetts 01801
United States of America
Phone: +1.781.222.9600
Number of Employees: 122

Description

Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Oncolytic immunotherapy is a cancer treatment that exploits the ability of certain viruses to selectively replicate in and directly kill tumors, as well as induce a potent, patient-specific, anti-tumor immune response. The company was founded by Philip Astley-Sparke, Colin Love and Robert Coffin in March 2015 and is headquartered in Woburn, MA.